Medifast, Inc. (MED)

Medifast Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	89.3	99.53	101.69	91.72	90.93	115.31	108.02	97.47	94.44	112.75	147.41	123.75	87.69	69.71	61.07	118	104.18	154.52	191.99	206.03
Short-Term Investments	77.97	73.99	60.98	72.88	71.42	54.65	55.49	58.96	55.6	45.01	-	-	-	-	-	4.06	5.36	5.38	5.44	6.88
Cash & Short-Term Investments	167.27	173.51	162.67	164.59	162.34	169.96	163.51	156.43	150.04	157.76	147.41	123.75	87.69	69.71	61.07	122.06	109.54	159.9	197.43	212.91
Cash Growth	3.04%	2.09%	-0.51%	5.22%	8.20%	7.73%	10.92%	26.41%	71.10%	126.31%	141.38%	1.38%	-19.95%	-56.40%	-69.07%	-42.67%	-37.21%	-5.90%	35.79%	102.27%
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.09
Inventory	20.23	23.21	30.2	39.36	42.42	40.1	39.6	46.27	54.59	58.23	68.9	96.9	118.86	145.28	156.97	188.97	180.04	129.61	95.79	62.23
Other Current Assets	14.18	11.12	13.57	9.57	9.64	14.93	21.21	16.88	19.4	8.29	12.52	9.67	16.24	14.6	25.26	13.23	17.28	11.54	11.1	6.63
Total Current Assets	201.68	207.84	206.44	213.52	214.4	224.98	224.32	219.58	224.03	224.28	228.82	230.32	222.78	229.58	243.3	324.26	306.87	301.05	304.32	281.86
Net Property, Plant & Equipment	38.46	41.24	43.45	46.32	48.68	51.29	53.34	65.52	67.11	69.17	71.11	73.05	75.65	77.93	79.89	80.75	80.59	63.19	55.44	40.73
Other Long-Term Assets	7.83	19.13	19.44	20.17	21.13	14.97	15.88	17.65	18.77	26.58	18.8	18.24	17.78	18.84	17.36	16.43	10.87	7.13	4.48	3.8
Total Assets	247.97	268.21	269.33	280.01	284.21	291.24	293.53	302.76	309.91	320.02	318.73	321.61	316.21	326.35	340.55	421.44	398.33	371.37	364.23	326.4
Accounts Payable	38.36	41.24	40.26	51.82	56.49	66.27	69.15	71.23	86.42	103.22	105.19	113.3	134.69	148.13	154.78	174.37	163.31	155.51	149.02	141.25
Short-Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27	-	-	-	-	-
Current Portion of Leases	4.6	5.47	5.92	6.16	6.18	6.11	6.03	5.96	5.89	5.47	5.41	5.41	5.78	6.13	6.38	6.66	6.52	5.4	4.96	3.65
Other Current Liabilities	-	-	-	2.63	1.49	-	-	-	-	1.42	4.3	13.03	0.43	-	-	-	-	-	-	-
Total Current Liabilities	42.96	46.71	46.18	60.6	64.16	72.38	75.18	77.19	92.3	110.11	114.9	131.74	140.89	154.26	188.16	181.03	169.83	160.91	153.98	144.9
Long-Term Leases	6.09	6.79	7.14	8.45	9.94	11.52	13.07	14.61	16.13	16.87	18.27	18.96	20.28	21.57	22.91	24.38	26.02	14.22	15.57	6.6
Total Long-Term Liabilities	6.09	6.79	7.14	8.45	9.94	11.52	13.07	14.61	16.13	16.87	18.27	18.96	20.28	21.57	22.91	24.38	26.02	14.22	15.57	6.6
Total Liabilities	49.05	53.5	53.33	69.05	74.1	83.9	88.25	91.8	108.43	126.98	133.16	150.71	161.17	175.83	211.07	205.41	195.85	175.13	169.55	151.5
Common Stock	0.01	0.01	0	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-6.4	-	-	-	-	-	-1.35	-12.5
Additional Paid-in Capital	40.41	38.23	37.32	34.7	33.14	31.01	30.4	27.96	26.57	24.11	21.54	19.03	21.56	18.62	-	12.83	12.02	12.95	10.61	8.71
Accumulated Other Comprehensive Income	0.23	0.22	0.18	0.24	0.18	0.35	0.03	0.02	0.25	0.14	0.12	0.03	0.02	0.39	0.27	0.13	0.11	0.12	0.08	0.1
Retained Earnings	158.27	176.24	178.49	176.01	176.78	175.98	174.85	182.97	174.65	168.78	163.89	151.83	139.85	131.5	129.2	203.05	190.33	183.16	185.34	178.56
Shareholders' Equity	198.92	214.71	216.01	210.96	210.11	207.34	205.28	210.96	201.48	193.04	185.56	170.9	155.04	150.52	129.48	216.02	202.47	196.24	194.69	174.89
Total Liabilities & Equity	247.97	268.21	269.33	280.01	284.21	291.24	293.53	302.76	309.91	320.02	318.73	321.61	316.21	326.35	340.55	421.44	398.33	371.37	364.23	326.4
Total Debt	10.69	12.26	13.07	14.61	16.13	17.63	19.1	20.57	22.01	22.34	23.67	24.38	26.05	27.7	56.29	31.04	32.54	19.62	20.52	10.25
Net Cash (Debt)	156.58	161.25	149.61	149.98	146.22	152.33	144.41	135.86	128.03	135.42	123.73	99.37	61.64	42.01	4.78	91.02	77	140.27	176.9	202.66
Net Cash Growth	7.08%	5.86%	3.60%	10.40%	14.21%	12.49%	16.71%	36.72%	107.70%	222.34%	2490.14%	9.18%	-19.95%	-70.05%	-97.30%	-55.09%	-52.85%	-11.12%	32.63%	119.20%
Net Cash Per Share	14.25	14.67	13.53	13.70	13.31	13.88	13.20	12.40	11.71	12.39	11.33	9.12	5.61	3.81	0.42	7.82	6.58	11.90	14.92	17.06
Book Value	198.92	214.71	216.01	210.96	210.11	207.34	205.28	210.96	201.48	193.04	185.56	170.9	155.04	150.52	129.48	216.02	202.47	196.24	194.69	174.89
Book Value Per Share	18.10	19.53	19.53	19.27	19.13	18.90	18.77	19.25	18.43	17.66	17.00	15.68	14.10	13.63	11.32	18.56	17.31	16.65	16.42	14.72
Tangible Book Value	198.92	214.71	216.01	210.96	210.11	207.34	205.28	210.96	201.48	193.04	185.56	170.9	155.04	150.52	129.48	216.02	202.47	196.24	194.69	174.89
Tangible Book Value Per Share	18.10	19.53	19.53	19.27	19.13	18.90	18.77	19.25	18.43	17.66	17.00	15.68	14.10	13.63	11.32	18.56	17.31	16.65	16.42	14.72

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q